RxDoctor Payments Data

Dan Vongtama, MD

Radiation Oncology · Stockton, CANPI 1245434083

Payments from drug & device makers

$285in general payments, 2019–2025

Across 7 payments — averaging $40.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Monteris Medical Corporation$128
  • AstraZeneca$60
  • Palette Life Sciences, Inc.$44
  • Zap Surgical Systems, Inc.$27
  • Teleflex LLC$26

What the payments were for

  • Food & beverage$285100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Monteris Medical Corporation2$128
AstraZeneca1$60
Palette Life Sciences, Inc.2$44
Zap Surgical Systems, Inc.1$27
Teleflex LLC1$26

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$285 in reported general payments places this provider in the 35th percentile of 627 radiation oncology providers in California.

See all radiation oncology providers in California

Medicare billing

Part B allowed, 2024
$288,126
Medicare patients
68
Services billed
1,356

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tamsulosin Hcl18$296

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Stockton

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →